D-0876-2023 Class II Terminated

Recalled by Amneal Pharmaceuticals Of New York, LLC — Brookhaven, NY

FDA drug recall D-0876-2023 was initiated by Amneal Pharmaceuticals Of New York, LLC on May 30, 2023 and is designated Class II. Reason for recall: Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification) The recall status is terminated (terminated Jun 10, 2025). Affected quantity: 9,056 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 21, 2023
Initiation Date
May 30, 2023
Termination Date
Jun 10, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,056 bottles

Product description

Extended Phenytoin Sodium Capsules, USP, 100 mg, Rx Only, 100 capsules per bottle, Distributed by: Amneal Pharmaceuticals LLC., Bridgewater, NJ 08807, NDC 65162-212-10.

Reason for recall

Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification)

Distribution pattern

LA, PA and OH.

Code information

Lot # HL00721A, Exp. 12/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0876-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0876-2023. Report a data issue: hello@regdatalab.com.